Recursion Pharmaceuticals Inc (NASDAQ: RXRX) on Monday, soared 0.60% from the previous trading day, before settling in for the closing price of $5.03. Within the past 52 weeks, RXRX’s price has moved between $3.79 and $12.36.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -35.28% annually for the last half of the decade. The company achieved an average annual earnings per share of 15.16%. With a float of $310.65 million, this company’s outstanding shares have now reached $399.15 million.
In terms of profitability, gross margin is -0.08%, operating margin of -960.64%, and the pretax margin is -962.73%.
Recursion Pharmaceuticals Inc (RXRX) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Recursion Pharmaceuticals Inc is 23.58%, while institutional ownership is 60.54%. The most recent insider transaction that took place on Mar 27 ’25, was worth 836,987. In this transaction Chief Executive Officer of this company sold 138,574 shares at a rate of $6.04, taking the stock ownership to the 1,117,450 shares. Before that another transaction happened on Mar 27 ’25, when Company’s Officer proposed sale 138,574 for $6.04, making the entire transaction worth $836,987.
Recursion Pharmaceuticals Inc (RXRX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 15.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.10% during the next five years compared to -35.28% drop over the previous five years of trading.
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Trading Performance Indicators
Recursion Pharmaceuticals Inc (RXRX) is currently performing well based on its current performance indicators. A quick ratio of 4.11 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 34.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.78, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.15 in one year’s time.
Technical Analysis of Recursion Pharmaceuticals Inc (RXRX)
Let’s dig in a bit further. During the last 5-days, its volume was 27.57 million. That was better than the volume of 24.26 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 60.43%.
During the past 100 days, Recursion Pharmaceuticals Inc’s (RXRX) raw stochastic average was set at 14.82%, which indicates a significant decrease from 25.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.49% in the past 14 days, which was lower than the 107.01% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.91, while its 200-day Moving Average is $6.33. However, in the short run, Recursion Pharmaceuticals Inc’s stock first resistance to watch stands at $5.22. Second resistance stands at $5.37. The third major resistance level sits at $5.48. If the price goes on to break the first support level at $4.96, it is likely to go to the next support level at $4.85. Assuming the price breaks the second support level, the third support level stands at $4.70.
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Key Stats
Market capitalization of the company is 2.06 billion based on 406,495K outstanding shares. Right now, sales total 58,840 K and income totals -463,660 K. The company made 14,750 K in profit during its latest quarter, and -202,490 K in sales during its previous quarter.
